Compagnie Lombard Odier SCmA lowered its stake in MetLife, Inc. (NYSE:MET – Free Report) by 7.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 164,691 shares of the financial services provider’s stock after selling 14,093 shares during the quarter. Compagnie Lombard Odier SCmA’s holdings in MetLife were worth $13,566,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds also recently bought and sold shares of MET. Norges Bank acquired a new stake in shares of MetLife in the second quarter worth $756,104,000. ABN AMRO Bank N.V. acquired a new position in MetLife during the second quarter valued at $178,669,000. Amundi lifted its stake in MetLife by 40.2% in the 2nd quarter. Amundi now owns 4,507,362 shares of the financial services provider’s stock worth $361,265,000 after acquiring an additional 1,292,107 shares in the last quarter. Man Group plc boosted its position in MetLife by 325.5% during the 2nd quarter. Man Group plc now owns 1,344,551 shares of the financial services provider’s stock worth $108,129,000 after acquiring an additional 1,028,554 shares during the period. Finally, Worldquant Millennium Advisors LLC grew its stake in MetLife by 1,028.2% during the 2nd quarter. Worldquant Millennium Advisors LLC now owns 856,905 shares of the financial services provider’s stock valued at $68,912,000 after acquiring an additional 780,955 shares in the last quarter. 94.99% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several research firms recently commented on MET. Weiss Ratings cut shares of MetLife from a “buy (b-)” rating to a “hold (c+)” rating in a report on Thursday. Wells Fargo & Company lifted their target price on shares of MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a research note on Tuesday, January 13th. Mizuho set a $102.00 price target on shares of MetLife in a report on Wednesday, January 14th. Keefe, Bruyette & Woods cut their price objective on MetLife from $92.00 to $90.00 and set an “outperform” rating for the company in a report on Tuesday, November 11th. Finally, Barclays set a $90.00 target price on MetLife in a research note on Thursday, January 8th. Two analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, MetLife has an average rating of “Moderate Buy” and an average price target of $95.64.
MetLife Price Performance
NYSE MET opened at $76.29 on Tuesday. MetLife, Inc. has a fifty-two week low of $65.21 and a fifty-two week high of $87.39. The stock’s 50-day moving average is $78.90 and its two-hundred day moving average is $78.81. The firm has a market cap of $50.27 billion, a P/E ratio of 16.23, a price-to-earnings-growth ratio of 0.68 and a beta of 0.77. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.20 and a quick ratio of 0.18.
MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.34 by $0.24. MetLife had a return on equity of 21.81% and a net margin of 4.38%.The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $31.43 billion. During the same quarter in the prior year, the company posted $2.08 EPS. The firm’s revenue was up 27.6% on a year-over-year basis. On average, analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.
MetLife Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 10th. Stockholders of record on Tuesday, February 3rd will be given a $0.5675 dividend. The ex-dividend date of this dividend is Tuesday, February 3rd. This represents a $2.27 dividend on an annualized basis and a dividend yield of 3.0%. MetLife’s dividend payout ratio (DPR) is currently 48.30%.
MetLife Company Profile
MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.
In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.
See Also
- Five stocks we like better than MetLife
- The buying spree that no one is talking about
- How to collect $500-$800 weekly (BlackRock’s system)
- Trump’s AI Secret: 100X Faster Than Nvidia
- NEW LAW: Congress Approves Setup For Digital Dollar?
- They just tried to kill gold
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
